Home
About
Overview
Sharing Data
ORCID
Help
History (22)
Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score =50% treated with front-line pembrolizumab.
Studies of a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)
Camelidae
The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma.
Biomarkers in lung cancer: from early detection to novel therapeutics and decision making.
See All 22 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Biomarkers in lung cancer: from early detection to novel therapeutics and decision making.
Biomarkers in lung cancer: from early detection to novel therapeutics and decision making. Biomark Med. 2008 Dec 01; 2(6):577-586.
View in:
PubMed
authors with profiles
Ravi Salgia